Structure via PubChem · Public domain (PubChem)
lifitegrast
Sign in to saveAlso known as compound 1g [PMID: 24900456], SAR 1118, SAR-1118, SAR-1118-023, Xiidra®, SAR1118
Lifitegrast, sold under the brand name Xiidra (), is a medication for the treatment of signs and symptoms of dry eye, a syndrome called keratoconjunctivitis sicca. Lifitegrast reduces inflammation by inhibiting inflammatory cell binding. It is often used as an alternative to ciclosporin (Ikervis, Restasis, Vevye, Verkazia or Cequa) for dry eye treatment including meibomian gland dysfunction and inflammatory dry eye.
Key facts
- Drug.ChEBI
- 133023
- Drug.ChEMBL
- 2048028
- Drug.image
- Lifitegrast skeletal.svg
- Drug.image_class
- skin-invert-image
- Drug.tradename
- Xiidra
- Drug.MedlinePlus
- a616039
- Drug.pregnancy_AU
- B1
- Drug.routes_of_administration
- Eye drops
- Drug.ATC_prefix
- S01
- Drug.ATC_suffix
- XA25
- Drug.legal_AU
- S4
- Drug.legal_CA
- Rx-only
- Drug.legal_US
- Rx-only
- Drug.CAS_number
- 1025967-78-5
- Drug.PubChem
- 11965427
- Drug.DrugBank
- DB11611
- Drug.ChemSpiderID
- 10139520
- Drug.UNII
- 038E5L962W
via Wikipedia infobox
Chemical data
- Formula
- C29H24Cl2N2O7S
- Molecular weight
- 615.5 g/mol
- IUPAC name
- (2S)-2-[[2-(1-benzofuran-6-carbonyl)-5,7-dichloro-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(3-methylsulfonylphenyl)propanoic acid
- SMILES
- CS(=O)(=O)C1=CC=CC(=C1)C[C@@H](C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl
- InChIKey
- JFOZKMSJYSPYLN-QHCPKHFHSA-N
- XLogP
- 4.7
- Polar surface area
- 142 Ų
- H-bond donors
- 2
- H-bond acceptors
- 7
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 2016
- Admin. routes
- topical
- Indications
- dry eye syndrome, allergic conjunctivitis, eye disease, graft versus host disease
via ChEMBL · EBI
Research
165 papersvia PubMed
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 614.068127
- Has use
- medication
Show 5 more facts
- chemical formula
- C₂₉H₂₄Cl₂N₂O₇S
- canonical SMILES
- CS(=O)(=O)C1=CC=CC(=C1)CC(C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl
- isomeric SMILES
- CS(=O)(=O)C1=CC(C[C@H](NC(=O)C2=C(Cl)C3=C(CN(CC3)C(=O)C4=CC5=C(C=CO5)C=C4)C=C2Cl)C(O)=O)=CC=C1
- subject has role
- eye drop
- Commons category
- Lifitegrast
Sources (2)
via Wikidata · CC0
~4 min read
Encyclopedic overview
5 sectionsContents
- Adverse effects
- Pharmacology
- Mechanism of action
- History
- References
{{Infobox drug | image = Lifitegrast skeletal.svg | image_class = skin-invert-image | alt = | caption =
| pronounce = | tradename = Xiidra | Drugs.com = | MedlinePlus = a616039 | pregnancy_AU = B1 | pregnancy_AU_comment = | pregnancy_category= | routes_of_administration = Eye drops | ATCvet = | ATC_prefix = S01 | ATC_suffix = XA25
Excerpted from Wikipedia’s “lifitegrast” article, available under the CC BY-SA 4.0 licence.